Want to see JP:160A full AI Analyst Report?
Top Page
As Partners CO.,LTD.
(160A)
Select Model
Select Model
Rating:65Neutral
Price Target:
¥2,173.00
▼(-29.45% Downside)
Action:Reiterated
Date:08/19/26
The score is primarily supported by strong financial growth and improving earnings power, but is held back by consistently high leverage and volatile free cash flow. Technicals are mixed/neutral and valuation is moderately attractive with a supportive dividend yield.
Positive Factors
Revenue and earnings expansion
Sustained multi-year revenue growth alongside sharply higher net income indicates stronger operating scale and earnings power. If the company maintains this trajectory, expanding profitability can support reinvestment, service capacity and resilience over the next several months.
Negative Factors
Persistently high leverage
Heavy reliance on debt leaves the company more exposed to refinancing costs, interest burdens and operating setbacks. High leverage can also restrict strategic flexibility, making future expansion more dependent on sustained earnings and cash generation.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and earnings expansion
Sustained multi-year revenue growth alongside sharply higher net income indicates stronger operating scale and earnings power. If the company maintains this trajectory, expanding profitability can support reinvestment, service capacity and resilience over the next several months.
Read all positive factors
As Partners CO.,LTD. (160A) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥7.14B
Dividend Yield3.52%
Average Volume (3M)33.94K
Price to Earnings (P/E)16.7
Beta (1Y)0.72
Revenue Growth-1.37%
EPS Growth-78.55%
CountryJP
Employees985
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)53.34
Shares Outstanding3,593,000
10 Day Avg. Volume16,980
30 Day Avg. Volume33,940
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)1.45
Price to Sales (P/S)0.32
P/FCF Ratio27.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)368
Revenue Forecast (FY)¥27.70B
As Partners CO.,LTD. Business Overview & Revenue Model
Company Description
AS Partners Co. Ltd. focuses on delivering comprehensive senior care solutions. The company's services include operating long-term residential nursing facilities, providing assistance with daily living activities, offering temporary respite care, ...
As Partners CO.,LTD. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
58
Neutral
Cash Flow
62
Positive
| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.85B | 23.66B | 17.92B | 17.15B | 12.78B | 11.52B |
| Gross Profit | 2.27B | 4.25B | 3.86B | 3.11B | 2.15B | 1.87B |
| EBITDA | 980.08M | 1.95B | 1.64B | 1.08B | 552.06M | 1.02B |
| Net Income | 190.83M | 1.18B | 956.66M | 563.57M | 229.71M | 484.94M |
Balance Sheet | ||||||
| Total Assets | 23.18B | 24.36B | 21.41B | 15.95B | 14.75B | 11.82B |
| Cash, Cash Equivalents and Short-Term Investments | 4.24B | 4.07B | 6.86B | 5.71B | 4.02B | 3.86B |
| Total Debt | 9.32B | 10.13B | 9.31B | 5.66B | 6.49B | 5.13B |
| Total Liabilities | 18.06B | 19.19B | 17.24B | 13.57B | 12.88B | 10.13B |
| Stockholders Equity | 5.12B | 5.17B | 4.16B | 2.38B | 1.86B | 1.68B |
Cash Flow | ||||||
| Free Cash Flow | 1.14B | 268.12M | -3.29B | 2.19B | -1.86B | -1.06B |
| Operating Cash Flow | 2.07B | 4.83B | 1.31B | 3.43B | -745.18M | -338.97M |
| Investing Cash Flow | -977.85M | -5.40B | -4.65B | -1.43B | -707.64M | 928.45M |
| Financing Cash Flow | -1.01B | 599.19M | 4.46B | -884.25M | 1.31B | -369.06M |
As Partners CO.,LTD. Technical Analysis
Negative
3080.00
Price Trends
2016.36
Negative
2043.07
Negative
2215.85
Negative
Market Momentum
-6.47
Positive
43.04
Neutral
25.50
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:160A, the sentiment is Negative. The current price of 3080 is above the 20-day moving average (MA) of 2028.50, above the 50-day MA of 2016.36, and above the 200-day MA of 2215.85, indicating a bearish trend. The MACD of -6.47 indicates Positive momentum. The RSI at 43.04 is Neutral, neither overbought nor oversold. The STOCH value of 25.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:160A.
As Partners CO.,LTD. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥45.65B | 11.34 | ― | 2.63% | 5.16% | 37.79% | |
65 Neutral | ¥7.14B | 16.68 | ― | 2.19% | -1.37% | -78.55% | |
56 Neutral | ¥2.50B | 29.72 | ― | 2.56% | -5.72% | -73.78% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | ¥5.48B | 52.37 | ― | 4.07% | 4.85% | -85.27% | |
46 Neutral | ¥4.11B | 12.30 | ― | 1.41% | 14.91% | -39.00% |
* General Sector Average
JP:160A
As Partners CO.,LTD.
1,991.00
-1,278.24
-39.10%
JP:2373
Care Twentyone Corporation
408.00
5.65
1.40%
JP:2425
Care Service Co., Ltd.
661.00
-120.55
-15.42%
JP:6062
Charm Care Corporation
1,404.00
380.24
37.14%
JP:7061
Japan Hospice Holdings Inc.
480.00
-805.84
-62.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.